Clinical trials
Phase 2 Adenocarcinoma of Lung trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 7 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Pulmonary Hospital, Shanghai, China | 4 |
| Henan Cancer Hospital | 3 |
| Sun Yat-sen University | 3 |
| Hunan Province Tumor Hospital | 2 |
| Novartis Pharmaceuticals | 2 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| First People's Hospital of Hangzhou | 1 |
| Fudan University | 1 |
| Fujian Cancer Hospital | 1 |
| Guangzhou Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 23 |
| Lung Neoplasms | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Adenocarcinoma, Bronchiolo-Alveolar | 1 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Bronchial Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Liposarcoma | 1 |
| Neoplasms by Histologic Type | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.